Webinar Date/Time: Tuesday, Dec 6, 2022, 11am PT | 2pm ET
Learn how commercial operations and brand marketing teams can partner for successful commercial strategies and tactical execution.
Register Free: https://www.pharmexec.com/pe_w/patient_data
Event Overview:
As HCP-engagement models and best practices evolve, there is an increased focus to adopt personalized, data-driven strategies to generate more effective physician conversations.
Key Learning Objectives:
Speakers Name and Title:
Meghana Sundaresan
Market Strategy and Innovation Lead, Commercial
Komodo Health
Meghana Sundaresan is the Market Strategy and Innovation Lead for Clinical Development at Komodo Health. She joined the Komodo Health team in 2020 after five years in healthcare and life sciences consulting, where she worked with several pharma and biotech organizations to design commercial strategies for launching therapies in the market as well as repositioning existing offerings to optimize growth. At Komodo, she continues to work closely with commercial teams to support critical needs for data and analytics across the organization. She is passionate about helping life sciences organizations unlock advanced data and analytical capabilities through powerful, easy-to-use technologies to maximize insight generation . Meghana holds a BS degree in Chemical Engineering from National Institute of Technology, Nagpur, India, and an MBA from UVA - Darden.
Mac Small
Area Vice President, Life Sciences
Komodo Health
Over his 15+ year career in healthcare technology Mac has developed a deep understanding of data, analytics, and the application of technology to serve the evolving needs in healthcare. He has held roles across IT, product, analytics, operations, and business development, creating a comprehensive base from which to develop innovative solutions to serve both internal and external customers. At Komodo Health, he partners with Life Sciences organizations to enable accurate, near real-time insights that enable unified decision making across marketing, sales, operations, and technology franchises.
Times and Date:
Tuesday, Dec 6, 2022, 11am PT | 2pm ET
Sponsor:
Komodo Health
Register Free: https://www.pharmexec.com/pe_w/patient_data
Addressing Disparities in Psoriasis Trials: Takeda's Strategies for Inclusivity in Clinical Research
April 14th 2025LaShell Robinson, Head of Global Feasibility and Trial Equity at Takeda, speaks about the company's strategies to engage patients in underrepresented populations in its phase III psoriasis trials.
Bristol Myers Squibb’s Cobenfy Falls Short in Phase III Trial as Add On Therapy for Schizophrenia
April 23rd 2025In the Phase III ARISE trial, Cobenfy administered as an adjunctive treatment to atypical antipsychotics for patients with inadequately controlled schizophrenia did not achieve statistically significant improvements.